(VIANEWS) - Kinder Morgan (KMI), OrthoPediatrics Corp. (KIDS), Hyatt Hotels Corporation (H) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Kinder Morgan (KMI)
33.3% sales growth and 8.11% return on equity
Kinder Morgan, Inc. operates as an energy infrastructure company in North America. The company operates through four segments: Natural Gas Pipelines, Products Pipelines, Terminals, and CO2. The Natural Gas Pipelines segment owns and operates interstate and intrastate natural gas pipeline, and underground storage systems; natural gas gathering systems and natural gas processing and treating facilities; natural gas liquids fractionation facilities and transportation systems; and liquefied natural gas liquefaction and storage facilities. The Products Pipelines segment owns and operates refined petroleum products, and crude oil and condensate pipelines; and associated product terminals and petroleum pipeline transmix facilities. The Terminals segment owns and/or operates liquids and bulk terminals that stores and handles various commodities, including gasoline, diesel fuel, chemicals, ethanol, metals, and petroleum coke; and owns tankers. The CO2 segment produces, transports, and markets CO2 to recovery and production crude oil from mature oil fields; owns interests in/or operates oil fields and gasoline processing plants; and operates a crude oil pipeline system in West Texas, as well as owns and operates RNG and LNG facilities. It owns and operates approximately 83,000 miles of pipelines and 143 terminals. The company was formerly known as Kinder Morgan Holdco LLC and changed its name to Kinder Morgan, Inc. in February 2011. Kinder Morgan, Inc. was founded in 1936 and is headquartered in Houston, Texas.
Earnings Per Share
As for profitability, Kinder Morgan has a trailing twelve months EPS of $0.8.
PE Ratio
Kinder Morgan has a trailing twelve months price to earnings ratio of 23.07. Meaning, the purchaser of the share is investing $23.07 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.11%.Growth Estimates Quarters
For the current quarter, the company expects to grow by 14.8% while it will see a decline of 3.1% in the following.Dividend Yield
Morningstar, Inc. estimates that the next dividend payment will be made on October 27, 2022. The forward annual dividend rate for the year is estimated at 1.11, and the forward annual dividend yield to be 6.26%.
Revenue growth
The year-over-year revenue growth was 35.4%. We now have 19.05B in the 12 trailing months.
Volume
Today's last reported volume for Kinder Morgan is 11309800 which is 22.29% below its average volume of 14555100.
2. OrthoPediatrics Corp. (KIDS)
27.9% sales growth and 3.04% return on equity
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Earnings per Share
OrthoPediatrics Corp.'s trailing twelve-month EPS is $0.47.
PE Ratio
OrthoPediatrics Corp.'s trailing 12 months earnings to price ratio is 97.17. The purchaser of the shares is expected to invest $97.17 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a company, was 3.04%.Volume
OrthoPediatrics Corp.'s current reported volume is now 32356, which is 76.72% less than its average volume 139016.
Moving Average
OrthoPediatrics Corp. is worth more than its moving average for 50 days of $42.00, and over its moving average for 200 days of $45.19.3. Hyatt Hotels Corporation (H)
17.7% sales growth and 3.75% return on equity
Hyatt Hotels Corporation, a hospitality company, develops, owns, operates, manages, franchises, licenses, or provides services to hotels, resorts, and other properties. It operates through four segments: Owned and Leased Hotels, Americas Management and Franchising, ASPAC Management and Franchising, and EAME/SW Asia Management and Franchising. The company operates its properties under the Park Hyatt, Miraval, Grand Hyatt, Alila, Andaz, The Unbound Collection by Hyatt, Destination, Hyatt Regency, Hyatt, Hyatt Ziva, Hyatt Zilara, Thompson Hotels, Hyatt Centric, Caption by Hyatt, Hyatt House, Hyatt Place, tommie, Hyatt Residence Club, Hyatt Residences, Exhale, World of Hyatt, and Hyatt Resorts brands. As of June 30, 2020, its hotel portfolio consisted of approximately 900 hotels in 65 countries. It primarily serves corporations; national, state, and regional associations; specialty market accounts, including social, government, military, educational, religious, and fraternal accounts; travel agency and luxury organizations; and a group of individual consumers. Hyatt Hotels Corporation has a strategic alliance with Small Luxury Hotels to provide benefits to the members of World of Hyatt loyalty program by providing additional stay opportunities at luxury hotels primarily in Europe. The company was formerly known as Global Hyatt Corporation and changed its name to Hyatt Hotels Corporation in June 2009. Hyatt Hotels Corporation was founded in 1957 and is headquartered in Chicago, Illinois.
Earnings Per Share
As for profitability, Hyatt Hotels Corporation has a trailing twelve months EPS of $1.21.
PE Ratio
Hyatt Hotels Corporation has a trailing twelve months price to earnings ratio of 86.73. Meaning, the purchaser of the share is investing $86.73 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.75%.Moving Average
Hyatt Hotels Corporation's value is way above its 50-day moving average of $94.88 and way above its 200-day moving average of $88.32.4. LPL Financial Holdings (LPLA)
8.6% sales growth and 35.11% return on equity
LPL Financial Holdings Inc., together with its subsidiaries, provides an integrated platform of brokerage and investment advisory services to independent financial advisors and financial advisors at financial institutions in the United States. Its brokerage offerings include variable and fixed annuities, mutual funds, equities, retirement and education savings plans, fixed income, and insurance, as well as alternative investments, such as non-traded real estate investment trusts and business development companies. The company also provides advisory platforms that provide access to mutual funds, exchange-traded funds, stocks, bonds, certain option strategies, unit investment trusts, and institutional money managers and no-load multi-manager variable annuities. In addition, it offers money market programs; and retirement solutions for commission-and fee-based services that allow advisors to provide brokerage services, consultation, and advice to retirement plan sponsors. Further, the company provides other services comprising tools and services that enable advisors to maintain and grow their practices; trust, investment management oversight, and custodial services to trusts for estates and families, as well as insurance brokerage general agency services; and technology products, such as proposal generation, investment analytics, and portfolio modeling. The company was formerly known as LPL Investment Holdings Inc. and changed its name to LPL Financial Holdings Inc. in June 2012. LPL Financial Holdings Inc. was founded in 1989 and is based in San Diego, California.
Earnings per Share
LPL Financial Holdings' trailing 12 month EPS is $5.53.
PE Ratio
LPL Financial Holdings' trailing 12-month price-earnings ratio is 40.71. The purchaser of the shares is therefore investing $40.71 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 35.11%.Revenue growth
The year-over-year revenue growth was 7%. 8.36B is the current trailing month.
Volume
Today's last reported volume for LPL Financial Holdings is 330568 which is 66.09% below its average volume of 975122.
5. Insulet (PODD)
6.8% sales growth and 7.85% return on equity
Insulet Corporation designs, produces, and markets insulin delivery systems to people suffering from insulin-dependent diabetes. The Omnipod System is a disposable, self-adhesive, tubeless Omnipod device. It can be worn on the body up to 3 days. It sells products through independent distributors, pharmacy channels and directly within the United States, Canada and Europe. Insulet Corporation was founded in 2000. It is located in Acton in Massachusetts.
Earnings per Share
Insulet's trailing 12 month EPS is $0.1.
PE Ratio
Insulet's trailing 12 months earnings to price ratio is 2863.8 The purchaser of the shares is investing $2863.8 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 7.85%.Annual Top and Bottom Value
Insulet stock was valued at $286.38 at 5:23 EST at the time of writing. This is way lower than its 52 week high of $320.00, and far higher than its 52 week low of $181.00.
Moving Average
Insulet's worth is under its 50-day moving average of $297.44 and way higher than its 200-day moving average of $253.89.Sales Growth
Insulet is expecting 6.8% sales growth in the next quarter.
6. REX American Resources Corporation (REX)
5.3% sales growth and 10.9% return on equity
REX American Resources Corporation, together with its subsidiaries, produces and sells ethanol. It operates in two segments, Ethanol and By-Products, and Refined Coal. The company also offers distillers grains and non-food grade corn oil; and dry distillers grains with solubles, which is used as a protein in animal feed. In addition, it produces, processes, and sells refined coal. The company was formerly known as REX Stores Corporation and changed its name to REX American Resources Corporation in June 2010. REX American Resources Corporation was founded in 1980 and is headquartered in Dayton, Ohio.
Earnings per Share
REX American Resources Corporation's trailing 12 months earnings per share (EPS) is $2.36
PE Ratio
REX American Resources Corporation's trailing 12-month price-earnings ratio is 13.64. The purchaser of the shares is therefore investing $13.64 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 10.9%.